Skip to main content

Published locations for “The Nail in the Coffin for Fibrates”: Futility of PROMINENT Trial Definitively Settles Debate on Avoiding Use of Fibrate Class of Medications for Cardiovascular Risk Reduction

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. “The Nail in the Coffin for Fibrates”: Futility of PROMINENT Trial Definitively Settles Debate on Avoiding Use of Fibrate Class of Medications for Cardiovascular Risk Reduction

User login

  • Reset your password
  • /content/nail-coffin-fibrates-futility-prominent-trial-definitively-settles-debate-avoiding-use-fibrate-class-medications-cardiovascular-risk-reduction
  • /cardiology/article/260222/nail-coffin-fibrates-futility-prominent-trial-definitively-settles-debate